![Enrique Poradosu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enrique Poradosu
Founder at
NUVECTIS PHARMA, INC.
Net worth: 18 M $ as of 31/05/2026
Profile
Dr. Enrique Poradosu is a Chief Scientific & Business Officer, Executive VP at Nuvectis Pharma, Inc. Dr. Poradosu was previously employed as a Senior VP-Business & Scientific Strategy by Stemline Therapeutics, Inc. and a Vice President-Business & Scientific Strategy by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from The Hebrew University of Jerusalem and a doctorate degree from The Hebrew University of Jerusalem.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 1,806,319 ( 6.81% ) | 18 M $ | 31/05/2026 |
Enrique Poradosu active positions
| Companies | Position | Start |
|---|---|---|
| NUVECTIS PHARMA, INC. | Founder | 27/07/2020 |
Former positions of Enrique Poradosu
| Companies | Position | End |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2020 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Training of Enrique Poradosu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Enrique Poradosu
